Expression of Transforming Growth Factor‐β1 in Thymus of Myasthenia Gravis Patients
暂无分享,去创建一个
A. Annoni | R. Mantegazza | P. Confalonieri | F. Cornelio | P. Bernasconi | L. Passerini | C. Marcozzi | F. Ubiali
[1] J. Orenstein,et al. TGF-β influences the life and death decisions of T lymphocytes , 2000 .
[2] L. Sobin,et al. Histological Classification of Tumours of the Thymus , 1999 .
[3] F. Shi,et al. Cytokine and chemokine mRNA expressing cells in muscle tissues of experimental autoimmune myasthenia gravis , 1998, Journal of the Neurological Sciences.
[4] P. Tonali,et al. Low Level of TGF‐β in Early Stages of Myasthenia Gravis , 1998, Annals of the New York Academy of Sciences.
[5] H. Müller-Hermelink,et al. Pathogenesis of myasthenia gravis , 1997, Virchows Archiv.
[6] K. Schluns,et al. TGF-beta differentially modulates epidermal growth factor-mediated increases in leukemia-inhibitory factor, IL-6, IL-1 alpha, and IL-1 beta in human thymic epithelial cells. , 1997, Journal of immunology.
[7] L. Morandi,et al. Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. , 1995, The Journal of clinical investigation.
[8] S. Wahl,et al. Transforming growth factor beta: the good, the bad, and the ugly , 1994, The Journal of experimental medicine.
[9] K. Shortman. Cellular aspects of early T-cell development , 1992, Current Biology.
[10] M. Peuchmaur,et al. In situ production of interleukins in hyperplastic thymus from myasthenia gravis patients. , 1991, Human pathology.
[11] J. Sprent,et al. T Cell Selection in the Thymus , 1988, Immunological reviews.